Otros idiomas Mydecine Innovations Group Inc.

Acciones

MYCOF

CA62849F2008

Mercado cerrado - OTC Markets Otros sitios de cotización 15:48:02 10/05/2024			Varia. Cinco días.	Varia. 1 de enero.
0,0112 ^USD	+112,04 %		0,00 %	-24,83 %

23/02	Mydecine Innovations cierra la liquidación parcial de su deuda	MT
02/02	Mydecine Innovations Group Inc anuncia la dimisión de Neil Stevenson-Moore como director	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Mydecine Applies for Management Cease Trade Order	03/05
Mydecine Receives Management Cease Trade Order	03/05
Mydecine Innovations Group Inc. Announces Restructuring Transactions and Annual General and Special Meeting	02/05
Mydecine Innovations Group Inc. announced that it expects to receive CAD 1 million in funding	01/05
Mydecine Announces Intention to Refile Certain Financial Statements and Applies for Management Cease Trade Order	26/04
Mydecine Innovations Group Inc. Announces Share for Debt Settlement	20/03
Mydecine Innovations Closes Partial Debt Settlement	23/02
Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds	07/02
Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds	07/02
Mydecine Innovations Group Announces Director Resignation	02/02
Mydecine Innovations Group Inc Announces Resignation of Neil Stevenson-Moore as Director	02/02
Mydecine Innovations Group Receives Notice of Allowance from USPTO For MYCO-005 Compound	18/12
Mydecine Innovations Group Receives Notice of Allowance from USPTO for its MYCO-005 Compound	18/12
Mydecine Announces Update Regarding the Special Access Program	28/11
Mydecine Innovations Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	18/11
Mydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreements	31/10/23
Mydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreements	31/10/23
Mydecine Innovations Group Provided Q4 2023 Business Update	26/10/23
Mydecine Provides Q4 2023 Business Update	26/10/23
Mydecine Provides Q4 2023 Business Update	26/10/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Mydecine Innovations Group Inc.

Acciones

MYCOF

CA62849F2008

Otros idiomas

Filtros